John L. Goudreau

Affiliations: 
Neuroscience Michigan State University, East Lansing, MI 
Area:
Neuroscience Biology
Google:
"John Goudreau"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fortin JS, Benskey MJ, Lookingland KJ, et al. (2020) Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction. Bmc Veterinary Research. 16: 356
Winner BM, Zhang H, Farthing MM, et al. (2017) Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP. Frontiers in Aging Neuroscience. 9: 410
Patterson JR, Kim EJ, Goudreau JL, et al. (2016) FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure. Brain Research
Goudreau JL, Pérez A, Aminoff MJ, et al. (2016) Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America. Journal of the Neurological Sciences. 366: 74-81
Simkins TJ, Fried D, Parikh K, et al. (2016) Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology
Hawong HY, Patterson JR, Winner BM, et al. (2015) Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons. Brain Research. 1622: 240-51
Tiernan CT, Edwin EA, Hawong HY, et al. (2015) Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase. Toxicological Sciences : An Official Journal of the Society of Toxicology. 144: 347-56
Fang JY, Pérez A, Christine CW, et al. (2015) Parkinson's disease severity and use of dopaminergic medications. Parkinsonism & Related Disorders. 21: 297-9
Benskey MJ, Manfredsson FP, Lookingland KJ, et al. (2015) The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure. Neurotoxicology. 46: 1-11
Credle JJ, George JL, Wills J, et al. (2015) GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death and Differentiation. 22: 838-51
See more...